Results 181 to 190 of about 677,362 (304)
Lexical tone perception by CI users (Holt et al., 2018)
Colleen M. Holt +3 more
openalex +1 more source
Congenital Amusia (or Tone-Deafness) Interferes with Pitch Processing in Tone Languages [PDF]
Barbara Tillmann +5 more
openalex +1 more source
Tryptophan metabolite atlas uncovers organ, age, and sex‐specific variations
Tryptophan metabolites were analyzed across twelve organs, the central nervous system, and serum in male and female mice at three life stages. We found tissue‐, sex‐, and age‐specific differences, including increased indole‐3‐pyruvate and kynurenine in aging males.
Lizbeth Perez‐Castro +8 more
wiley +1 more source
Colorism and Health Inequities among Black Americans: A Biopsychosocial Perspective. [PDF]
Dennis AC +3 more
europepmc +1 more source
CSAR 62 as negative-tone resist for high-contrast e-beam lithography at temperatures between 4 K and room temperature [PDF]
Arsenty Kaganskiy +4 more
openalex +1 more source
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel +9 more
wiley +1 more source
Mathematical modelling and compensation strategies for printing dot gain. [PDF]
Liu X, Qiu B, Ling YL.
europepmc +1 more source
Robust DFT‐based generalised likelihood ratio test for underwater tone detection
Yilin Wang +4 more
openalex +2 more sources
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee +3 more
wiley +1 more source
Regression to the mean explains perception of action consequences. [PDF]
Johnen S, Zimmermann E.
europepmc +1 more source

